Innovation Series 2022: Live with Ali Urman (Analyst, ARK Invest)

Do you have any questions?

When: March 23rd, 2022

Where: Anywhere you are! 


  • Ali Urman (Analyst, ARK Invest)
  • Lisa Langley (CEO/Founder, Emerge Canada)

What: Ali Urman (Analyst, ARK Invest) reviews the Big Ideas 2022 report and answers questions regarding the EAGB strategy.

Some of the questions asked:

  • Where do you get your data from when it comes to clinical trial performance?
  • Could you provide comments on new positions that have been added recently?
  • What is something you’re optimistic about happening in the genomics space?